Popovich K J, Hiller C, Hough A, Norris J S, Cornett L E
Am J Physiol. 1984 Nov;247(5 Pt 1):C342-9. doi: 10.1152/ajpcell.1984.247.5.C342.
To establish a model of airway smooth muscle function we studied binding of [3H]dihydroalprenolol [( 3H]DHA), a beta-adrenergic antagonist, to membrane preparations of porcine trachealis muscle and investigated the response of adenylate cyclase to l-isoproterenol in tissue and plasma membranes. [3H]DHA binding was of high affinity (Kd = 1.0 +/- 0.1 nM), was saturable (Bmax = 87.6 +/- 13.2 fmol/mg protein), and was 90% beta 2 and 10% beta 1. Adenylate cyclase activity in the membrane preparation was (in pmol.10 min-1.mg protein-1 +/- SE): basal 420 +/- 74, guanosine 5'-triphosphate (GTP) (10 micron) 600 +/- 45, GTP (10 microM) + l-isoproterenol (100 microM) 660 +/- 63, NaF (10 mM) 1,500 +/- 134, and forskolin (100 microM) 3,000 +/- 410. Guanosine 5'-diphosphate (GDP) and GTP were active cofactors; l-isoproterenol appeared to function as an effector exchanging GTP for GDP on the guanine nucleotide regulatory protein. There was close agreement of the effective dose (ED50) of the l-isoproterenol-induced relaxation (0.95 +/- 0.45 microM) and the inhibitory constant of l-isoproterenol binding (0.39 +/- 0.10 microM). l-Isoproterenol (100 microM) induced a 100% increase in adenosine 3',5'-cyclic monophosphate (cAMP) levels in tissue strips over basal activity. Investigation of the difference in adenylate cyclase activity between tissue and plasma membranes revealed that l-isoproterenol responsive adenylate cyclase was diminished after initial homogenization. Electron microscopy demonstrated disruption of all cells at this early stage of preparation. The decrease in l-isoproterenol responsive adenylate cyclase following cell rupture is different from other tissues and suggests a difference in the actions of beta-agonist in smooth muscle compared with other tissues.
为建立气道平滑肌功能模型,我们研究了β-肾上腺素能拮抗剂[³H]二氢阿普洛尔([³H]DHA)与猪气管平滑肌膜制剂的结合,并研究了腺苷酸环化酶在组织和质膜中对l-异丙肾上腺素的反应。[³H]DHA结合具有高亲和力(Kd = 1.0±0.1 nM),可饱和(Bmax = 87.6±13.2 fmol/mg蛋白),且90%为β₂型,10%为β₁型。膜制剂中的腺苷酸环化酶活性(以pmol·10分钟⁻¹·mg蛋白⁻¹±标准误表示):基础活性为420±74,鸟苷5'-三磷酸(GTP)(10 μM)时为600±45,GTP(10 μM)+ l-异丙肾上腺素(100 μM)时为660±63,氟化钠(10 mM)时为1500±134,福斯可林(100 μM)时为3000±410。鸟苷5'-二磷酸(GDP)和GTP是活性辅助因子;l-异丙肾上腺素似乎作为一种效应物,在鸟嘌呤核苷酸调节蛋白上用GTP交换GDP。l-异丙肾上腺素诱导的舒张的有效剂量(ED50)(0.95±0.45 μM)与l-异丙肾上腺素结合的抑制常数(0.39±0.10 μM)非常一致。l-异丙肾上腺素(100 μM)使组织条中的腺苷3',5'-环化单磷酸(cAMP)水平比基础活性增加了100%。对组织和质膜中腺苷酸环化酶活性差异的研究表明,在初始匀浆后,l-异丙肾上腺素反应性腺苷酸环化酶减少。电子显微镜显示在制备的这个早期阶段所有细胞均被破坏。细胞破裂后l-异丙肾上腺素反应性腺苷酸环化酶的减少与其他组织不同,提示与其他组织相比,β-激动剂在平滑肌中的作用存在差异。